Hap Trading, LLC Sio Gene Therapies Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.25 - $0.73 $6,050 - $17,666	-24,200 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.55 - $1.47 $7,480 - $19,992	13,600 Added 128.3%	24,200 $0
Q4 2021 Feb 14, 2022	SELL	$1.29 - $2.36 $4,257 - $7,788	-3,300 Reduced 23.74%	10,600 $2,000
Q3 2021 Nov 10, 2021	BUY	$1.81 - $2.7 $25,159 - $37,530	13,900 New	13,900 $4,000
Q1 2021 May 14, 2021	SELL	$2.34 - $3.44 $44,928 - $66,048	-19,200 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $36,672 - $108,096	19,200 New	19,200 $4,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.